Unified Patent Court rules Enanta's '265 patent invalid in Pfizer litigation

The Unified Patent Court ruled Enanta Pharmaceuticals' '265 patent invalid, a decision in the ongoing patent infringement lawsuit Enanta brought against Pfizer.

Detected & updated continuously · Source: Nebula

Story subjects

Track sentiment and mindshare across stocks and crypto in Nebula.

Open Nebula